Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,035
archived clinical trials in
Bipolar Disorder

Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-Meriden
mi
from
Meriden, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-Meriden
mi
from
Meriden, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.- Middletown
mi
from
Middletown, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.- Middletown
mi
from
Middletown, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-New Britain
mi
from
New Britain, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-New Britain
mi
from
New Britain, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-New London
mi
from
New London, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-New London
mi
from
New London, CT
Click here to add this to my saved trials
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents
Status: Enrolling
Updated:  8/28/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents
Status: Enrolling
Updated: 8/28/2017
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Cedars Sinai Department of Psychiatry
mi
from
Los Angeles, CA
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Cedars Sinai Department of Psychiatry
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Asher Depression Center, Northwestern University
mi
from
Chicago, IL
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Asher Depression Center, Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated:  9/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Memantine and Cognitive Dysfunction in Bipolar Disorder
Memantine and Cognitive Dysfunction in Bipolar Disorder
Status: Enrolling
Updated: 9/7/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
Pilot Study of Glycine Augmentation in Carriers of a Mutation in the Gene Encoding Glycine Decarboxylase
Status: Enrolling
Updated:  9/18/2017
McLean Hospital
mi
from
Belmont, MA
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
Pilot Study of Glycine Augmentation in Carriers of a Mutation in the Gene Encoding Glycine Decarboxylase
Status: Enrolling
Updated: 9/18/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated:  10/3/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Insulin Resistance in Patients With Major Depression
Insulin Resistance in Patients With Major Depression
Status: Enrolling
Updated: 10/3/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
Status: Enrolling
Updated:  10/3/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
Status: Enrolling
Updated: 10/3/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
Status: Enrolling
Updated:  10/4/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression
Status: Enrolling
Updated: 10/4/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Examination of Brain Serotonin Receptors in Patients With Mood Disorders
Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Examination of Brain Serotonin Receptors in Patients With Mood Disorders
Serotonin1A Receptor and Serotonin Transporter Imaging In Mood Disorders
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pilot Trial of Peer Support for Bipolar Disorder
Pilot Trial of Peer Support for Bipolar Disorder
Status: Enrolling
Updated:  10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Pilot Trial of Peer Support for Bipolar Disorder
Pilot Trial of Peer Support for Bipolar Disorder
Status: Enrolling
Updated: 10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole
Status: Enrolling
Updated:  10/19/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
Reducing Medical Risks in Individuals With Bipolar Disorder: Enhancing Outcomes With Aripiprazole
Status: Enrolling
Updated: 10/19/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Status: Enrolling
Updated:  10/27/2017
Dubois Regional Medical Center
mi
from
Dubois, PA
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Status: Enrolling
Updated: 10/27/2017
Dubois Regional Medical Center
mi
from
Dubois, PA
Click here to add this to my saved trials
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Status: Enrolling
Updated:  10/27/2017
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Status: Enrolling
Updated: 10/27/2017
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated:  11/13/2017
New York State Psychiatric Institute
mi
from
New York, NY
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated: 11/13/2017
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Massachusetts General Hospital
mi
from
Boston, MA
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Touchstone innovare
mi
from
Grand Rapids, MI
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Touchstone innovare
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Community Council of Nashua
mi
from
Nashua, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Community Council of Nashua
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
University of Alabama Psychology Clinic
mi
from
Birmingham, AL
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
University of Alabama Psychology Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Centerstone Research Institute
mi
from
Bloomington, IN
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Centerstone Research Institute
mi
from
Bloomington, IN
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Massachusetts Mental Health Center
mi
from
Boston, MA
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Massachusetts Mental Health Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
University of Minnesota Psychological Clinic
mi
from
Minneapolis, MN
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
University of Minnesota Psychological Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
West Central Behavioral Health
mi
from
Claremont, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
West Central Behavioral Health
mi
from
Claremont, NH
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Riverbend Community Mental Health Center
mi
from
Concord, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Riverbend Community Mental Health Center
mi
from
Concord, NH
Click here to add this to my saved trials
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated:  11/27/2017
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Status: Enrolling
Updated: 11/27/2017
Mental Health Center of Greater Manchester
mi
from
Manchester, NH
Click here to add this to my saved trials
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
Activating Consumers to Exercise in Community Psychiatry Through Peer Support
Status: Enrolling
Updated:  12/4/2017
Johns Hopkins University
mi
from
Baltimore, MD
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
Activating Consumers to Exercise in Community Psychiatry Through Peer Support
Status: Enrolling
Updated: 12/4/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acute Psychotherapy for Bipolar II Depression
Acute Psychotherapy for Bipolar II Depression
Status: Enrolling
Updated:  12/7/2017
WPIC/ Bellefield Towers/Depression and Manic Depression Prevention Program
mi
from
Pittsburgh, PA
Acute Psychotherapy for Bipolar II Depression
Acute Psychotherapy for Bipolar II Depression
Status: Enrolling
Updated: 12/7/2017
WPIC/ Bellefield Towers/Depression and Manic Depression Prevention Program
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
Mainline Health Systems Inc.
mi
from
Eudora, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
Mainline Health Systems Inc.
mi
from
Eudora, AR
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
Boston Mountain Rural Health Center
mi
from
Huntsville, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
Boston Mountain Rural Health Center
mi
from
Huntsville, AR
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
Lee County Cooperative Clinic
mi
from
Marianna, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
Lee County Cooperative Clinic
mi
from
Marianna, AR
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
ARcare
mi
from
Melbourne, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
ARcare
mi
from
Melbourne, AR
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
Jefferson Comprehensive Care System
mi
from
Pine Bluff, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
Jefferson Comprehensive Care System
mi
from
Pine Bluff, AR
Click here to add this to my saved trials
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated:  12/7/2017
East Arkansas Family Health Center
mi
from
West Memphis, AR
Implementation Trial of Evidence Based Practices for Mood Disorders
Partnership for Implementation of Evidence-Based Practices in Rural Primary Care
Status: Enrolling
Updated: 12/7/2017
East Arkansas Family Health Center
mi
from
West Memphis, AR
Click here to add this to my saved trials
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)
Improving PTSD Service Delivery for Veterans With Severe Mental Illness
Status: Enrolling
Updated:  1/11/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)
Improving PTSD Service Delivery for Veterans With Severe Mental Illness
Status: Enrolling
Updated: 1/11/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Iloperidone in Mixed States of Bipolar Disorder
Open Label Study of Iloperidone (IL) as Adjunctive Treatment in Mixed States (MS) of Bipolar Disorder (BD)
Status: Enrolling
Updated:  1/12/2018
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
Iloperidone in Mixed States of Bipolar Disorder
Open Label Study of Iloperidone (IL) as Adjunctive Treatment in Mixed States (MS) of Bipolar Disorder (BD)
Status: Enrolling
Updated: 1/12/2018
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Drug Treatment for Alcoholics With Bipolar Disorder
Efficacy of Valproate Maintenance in Bipolar Alcoholics
Status: Enrolling
Updated:  1/16/2018
Department of Psychiatry, Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Drug Treatment for Alcoholics With Bipolar Disorder
Efficacy of Valproate Maintenance in Bipolar Alcoholics
Status: Enrolling
Updated: 1/16/2018
Department of Psychiatry, Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Stanford University
mi
from
Stanford, CA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Naltrexone for Antipsychotic-Induced Weight Gain
Naltrexone for Antipsychotic-Induced Weight Gain
Status: Enrolling
Updated:  1/19/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Naltrexone for Antipsychotic-Induced Weight Gain
Naltrexone for Antipsychotic-Induced Weight Gain
Status: Enrolling
Updated: 1/19/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions.
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services
mi
from
Pittsburgh, PA
Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions
A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions.
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions
A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Arkansas Research
mi
from
Little Rock, AR
Bioequivalency Study of 450 mg Lithium Carbonate Under Fed Conditions
A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Arkansas Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions
A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
Arkansas Research
mi
from
Little Rock, AR
Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions
A Single Dose, Three-Treatment, Three-Period, Six-Sequence Crossover Bioequivalency Study of 450 mg Lithium Carbonate Extended Release Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Arkansas Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Novum Pharmaceutical Research Services, 11248 Wilcrest Green, , Houston77042
mi
from
Houston, TX
Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Novum Pharmaceutical Research Services, 11248 Wilcrest Green, , Houston77042
mi
from
Houston, TX
Click here to add this to my saved trials